Akums Drugs & Pharmaceuticals Ltd. (AKUMS) Drugs & Pharmaceuticals 52 Week High Streak: Second Straight Session Near One-Year Peak

Akums Drugs & Pharmaceuticals 52 Week High Streak has now held for its second straight session, with the share trading within 2% of its 52-week high across the streak and moving 1.12% over that span. The stock’s latest high in the move was Rs 825.25, while the current price stood at Rs 823.85 as of 08 October 2026 at 9:22 AM IST. According to latest Univest data, the pattern is confirmed, but it does not establish any company-specific catalyst for the continued move.

Akums Drugs & Pharmaceuticals share price was last at Rs 823.85, up Rs 1.75 or 0.21% from the previous close of Rs 822.10. It opened at Rs 819.95 and moved between Rs 817.35 and Rs 825.25 in the morning trade window. With a market capitalisation of Rs 12,822.89 crore, the repeated near-high pattern matters more than a one-off print because it shows the stock is staying close to its yearly high rather than briefly touching it once.

Akums Drugs & Pharmaceuticals 52 Week High Streak: Consecutive High Analysis

Metric	Value
Current Price	Rs 823.85
Previous Close	Rs 822.1
Today's Move	+Rs 1.75 (+0.21%)
Open	Rs 819.95
High	Rs 825.25
Low	Rs 817.35
Market Capitalisation	Rs 12,822.89 crore

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) traded at Rs 823.85 versus the previous close of Rs 822.1, a rise of 0.21%. The stock opened at Rs 819.95, reached a high of Rs 825.25 and touched a low of Rs 817.35.

Akums Drugs & Pharmaceuticals share price is trading at Rs 823.85, a gain of Rs 1.75 or 0.21% over the previous close of Rs 822.10. The stock opened at Rs 819.95, touched a high of Rs 825.25 and a low of Rs 817.35, leaving the current level near the upper end of the day’s range as of 08 October 2026 at 9:22 AM IST. For readers tracking Akums Drugs & Pharmaceuticals stock news, the day’s action keeps the share within the same narrow band that has supported the Akums Drugs & Pharmaceuticals 52 Week High Streak. The company’s market cap is Rs 12,822.89 crore, placing the current move in a mid-sized listed pharmaceutical business context rather than a broad market leader. On this day, Akums Drugs & Pharmaceuticals NSE and BSE movement reflects a modest price advance rather than a sharp gap move. The Akums Drugs & Pharmaceuticals Share Price Today context therefore remains focused on price stability near the one-year peak rather than an isolated spike.

What the Repeated 52-Week Highs Show

Akums Drugs & Pharmaceuticals 52 Week High Streak is best understood as a repeated near-peak pattern, not as a statement that the stock has broken into a new record zone. The cumulative streak move is 1.12%, which gives investors a cleaner read on the full stretch than a single morning print. Because the stock has remained within 2% of its one-year high for a second straight session, Akums Drugs & Pharmaceuticals Consecutive 52 Week High tracking becomes more relevant than a one-day headline. This is also where the Akums Drugs & Pharmaceuticals Share Price narrative differs from the first breakout day: the focus shifts from the initial move to whether the share can keep trading close to the yearly high without slipping back materially. The latest Univest data confirms the price pattern, but it does not establish a company-specific catalyst for the repeated near-high trade. For market watchers, that makes Akums Drugs & Pharmaceuticals New One Year High searches and Akums Drugs & Pharmaceuticals Back To Back 52 Week Highs searches useful for context, while the real story remains the persistence of the pattern across sessions.

From a reader’s point of view, this kind of streak is more informative than a single touch of the peak because it shows whether the stock can keep holding near its 52-week high during normal intraday movement. The phrase Akums Drugs & Pharmaceuticals 52 Week High For second straight session captures that persistence better than a one-day label. In practical terms, the stock is still trading close to its 52-week peak, and that is the key fact investors monitoring Stocks Hitting 52 Week Highs and Stocks At One Year High Today usually want to see.

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 12,822.89 crore
P/E Ratio	44.36x
P/B Ratio	3.79x
ROE	8.06%
ROCE	14.77%
EPS	Rs 18.53
Book Value Per Share	Rs 216.98
Dividend Yield	0.36%

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) fundamental metrics show P/E 44.36x, P/B 3.79x, ROE 8.06%, ROCE 14.77%. These figures provide context only and are not a buy or sell signal.

Akums Drugs & Pharmaceuticals Ltd. has a market capitalisation of Rs 12,822.89 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 44.36x, P/B at 3.79x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 8.06% and ROCE of 14.77%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 18.53, book value per share of Rs 216.98, dividend yield of 0.36%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.91x, median ROE of 11.61%, median ROCE of 13.28%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	44.36x
Benchmark Median P/E	27.91x
Benchmark Average P/E	41.15x
Benchmark P/E Range	0x to 708.87x
Company P/B Ratio	3.79x
Benchmark Median P/B	2.81x
Company ROE	8.06%
Benchmark Median ROE	11.61%
Company ROCE	14.77%
Benchmark Median ROCE	13.28%
Company Market Capitalisation	Rs 12,822.89 crore
Benchmark Median Market Cap	Rs 828.13 crore

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a P/E ratio of 44.36x, which is above the benchmark median of 27.91x, a difference of +58.94%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a ROE of 8.06%, which is below the benchmark median of 11.61%, a difference of -30.58%. Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a ROCE of 14.77%, which is above the benchmark median of 13.28%, a difference of +11.22%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sudeep Pharma Ltd.	SUDEEPPHRM	13,080.58	72.16	14.26	25.37	28.5
CORONA Remedies Ltd.	CORONA	12,461.67	62.68	15.46	27.36	31.74
Concord Biotech Ltd.	CONCORDBIO	14,306.79	51.56	6.85	13.54	18.04
Marksans Pharma Ltd.	MARKSANS	14,698.37	28.53	4.64	15.31	21.1
Astrazeneca Pharma India Ltd.	ASTRAZEN	14,796.38	87.23	16.36	23.02	31.24

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a P/E ratio of 44.36x compared with the displayed peer median of 62.68x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 8.06% compares with a peer median of 23.02% across the companies shown in the table. ROCE stood at 14.77% versus the displayed peer median of 28.5%, providing a capital-efficiency comparison. Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a market capitalisation of Rs 12,822.89 crore. Among the 5 peers shown, 4 have a larger market capitalisation.

Why Investors Are Watching Akums Drugs & Pharmaceuticals

• Akums Drugs & Pharmaceuticals 52 Week High Streak has lasted for a second straight session, keeping the stock near its one-year peak.
• The cumulative move across the streak is 1.12%, which gives a cleaner read than the day-only change.
• Akums Drugs & Pharmaceuticals share price is trading at Rs 823.85, close to the day’s high of Rs 825.25.
• The company’s P/E of 44.36 and P/B of 3.79 keep Akums Drugs & Pharmaceuticals Fundamental Analysis relevant for valuation watchers.
• Healthcare sector peers trade at a wide range of valuations, making Akums Drugs & Pharmaceuticals Stock News useful for comparison.

About Akums Drugs & Pharmaceuticals Ltd.

Akums Drugs & Pharmaceuticals Ltd. is a listed pharmaceutical company in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company has a market capitalisation of Rs 12,822.89 crore and is tracked on both NSE and BSE. Key financial markers include a P/E of 44.36, P/B of 3.79, ROE of 8.06%, ROCE of 14.77%, EPS of Rs 18.53 and book value of Rs 216.98. Its dividend yield stands at 0.36%.

For readers tracking Akums Drugs & Pharmaceuticals Share Price Update, the company sits in a competitive industry where valuation, return ratios and the ability to stay near a 52-week high all matter at the same time. That is why Akums Drugs & Pharmaceuticals Share Price and Akums Drugs & Pharmaceuticals Stock Performance remain closely watched in market updates.

Investor note: This article is for information only and is based on the latest market figures. It is not investment advice.

Frequently Asked Questions

Why is Akums Drugs & Pharmaceuticals still near its 52-week high?

Ans. Akums Drugs & Pharmaceuticals 52 Week High Streak reflects two consecutive sessions near the one-year peak. According to latest Univest figures, the pattern is confirmed, but no company-specific catalyst is identified in the market data.

How many sessions has AKUMS traded within 2% of its 52-week high?

Ans. AKUMS has traded within 2% of its 52-week high for a second straight session. That is the key feature behind the Akums Drugs & Pharmaceuticals Consecutive 52 Week High headline.

What is the cumulative move across the streak?

Ans. The cumulative streak move is 1.12%. That figure captures the full near-high stretch better than a single-day move and is the main differentiator for this Akums Drugs & Pharmaceuticals 52 Week High Streak update.

What is the latest Akums Drugs & Pharmaceuticals share price?

Ans. The share was last trading at Rs 823.85, up Rs 1.75 or 0.21% from the previous close of Rs 822.10. It moved between Rs 817.35 and Rs 825.25 in morning trade.

Is Akums Drugs & Pharmaceuticals overbought? How does the company look on valuation?

Ans. Akums Drugs & Pharmaceuticals Fundamental Analysis shows a P/E of 44.36 and a P/B of 3.79. Both are above the industry median in the healthcare peer set, so the valuation remains an important watch point.

How does AKUMS compare with peers?

Ans. AKUMS trades at lower valuation multiples than some richer peers such as Sudeep Pharma Ltd. and Astrazeneca Pharma India Ltd., but above value-oriented names like Natco Pharma Ltd. The peer set shows a wide spread in pricing and returns.

What should investors monitor next?

Ans. Investors can watch whether Akums Drugs & Pharmaceuticals Share Price continues to stay near the one-year high and whether the market cap, valuation ratios and return metrics continue to justify the premium. The current data confirms the pattern, not the reason behind it.

Track Akums Drugs & Pharmaceuticals Ltd. (AKUMS) Share Price on Univest

Use Akums Drugs & Pharmaceuticals Ltd. (AKUMS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.